However, multivariate Cox regression results showed that IDO had no significant correlation with the prognosis of ESCC patients, suggesting that serum HMGB1 was more valuable than IDO in predicting the prognosis of ESCC patients. The gene discussed is HMGB1; the disease is esophageal squamous cell carcinoma.